FDMT
#2620
4D Molecular Therapeutics, Inc. - Common Stock
12.9 9 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.55%
Variación mensual
-4.77%
Variación en los últimos 6 meses
+32.28%
Cambio anual
+14.96%
Cierres anteriores
13.3 3
Open
13.3 0
Mínimo
12.8 7
Máximo
13.4 7
Financials
- Market Capitalization 717.62 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.1
Relación precio/flujo de caja
5.1
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2612 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 13.24 USD | -3.00% | -7.48% | -19.42% | -3.99% | 710.06 M USD | ||
| 2615 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.64 USD | -2.38% | -5.75% | -17.17% | +8.61% | 729.73 M USD | ||
| 2628 |  DSGN Design Therapeutics, Inc. - Common Stock | 10.91 USD | -6.35% | -12.79% | -25.83% | +61.63% | 682.77 M USD | ||
| 2636 |  MDXG MiMedx Group, Inc - Common Stock | 4.82 USD | +3.21% | +5.93% | +6.17% | -26.75% | 702.57 M USD |